I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life.

Adjuvant ribociclib plus an aromatase inhibitor is now an FDA-approved treatment in HR-positive, HER2-negative stage II and III early breast cancer at a high risk of recurrence.

Aromatase inhibitors don’t take the place of chemo or surgery, but they can help some people living with ovarian cancer.

Hormone therapy for breast cancer – such as tamoxifen and aromatase inhibitors – can help prevent the cancer from coming back. If you have side effects, these things may help.

A new risk model uses baseline sociodemographic and financial measures to predict which patients prescribed long-term therapy with aromatase inhibitors for breast cancer are at significantly ...

Endocrine therapy could significantly contribute to metabolic changes; however, there is a lack of data on the effects of aromatase inhibitors and SERMs on the eating patterns of patients.

Aromatase inhibitors improved disease-free survival when compared with tamoxifen in HR+, HER2- early breast cancer, regardless of menopausal status.

Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among premenopausal women with ER-positive disease who received ovarian suppression, according to a ...

Aromatase inhibitors inhibit the natural production of estrogen by blocking aromatase, an enzyme required for generating the hormone. These drugs are typically used to treat postmenopausal women.

Aromatase inhibitors, drugs which block oestrogen production, are even more effective than tamoxifen in postmenopausal women, reducing this risk by a further 30%.

Premenopausal women with ER-positive breast cancer experienced a decreased rate of recurrence when given an aromatase inhibitor, compared with those given tamoxifen. However, more research is still ...

Aromatase inhibitors may reduce breast cancer recurrence compared with tamoxifen for certain postmenopausal women with breast cancer, according to study results presented at San Antonio Breast ...